|
Volumn 20, Issue 3, 2005, Pages 249-250
|
Putting the cart before the horse: A cautious look at the role of IgM-enriched polyclonal immunoglobulin in sepsis therapy
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CORTICOSTEROID;
DROTRECOGIN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INSULIN;
CAUSE OF DEATH;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
CRITICAL ILLNESS;
DRUG EFFICACY;
FLUID THERAPY;
HEALTH CARE COST;
HUMAN;
INSULIN TREATMENT;
LOW DRUG DOSE;
NOTE;
SEPSIS;
SEPTIC SHOCK;
COST-BENEFIT ANALYSIS;
GERMANY;
HUMANS;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN M;
LENGTH OF STAY;
QUALITY-ADJUSTED LIFE YEARS;
SEPSIS;
SHOCK, SEPTIC;
|
EID: 27144525217
PISSN: 08839441
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcrc.2005.06.002 Document Type: Note |
Times cited : (4)
|
References (8)
|